FIGS FIGS Q2 2026 earnings

“FIGS' exceptional Q2 performance was powered by strong, ongoing traction across the business, with outperformance on both the top and bottom lines. We delivered our third straight quarter of 25%-plus net revenues growth, our net revenues per active customer exceeded COVID-era highs, and our adjusted EBITDA margin grew significantly to 18.6%. Most notably, our success did not just come from one area of the business, but instead was broad-based across categories, geographies and channels. Looking forward, the unique combination of our product innovation engine and our ability to connect with our community is creating long-lasting impact for healthcare professionals. And given that we are still only serving a tiny percentage of the world's healthcare professionals, we believe we are just getting started.”